HepG2 cells as an in vitro model for evaluation of cytochrome P450 induction by xenobiotics

Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins

(2012) H. H. J. Gerets et al.   CELL BIOLOGY AND TOXICOLOGY

Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma

(2011) Hany A. Omar et al.   HEPATOLOGY

Induction of cytochromes P450 1A1 and 1A2 by tanshinones in human HepG2 hepatoma cell line

(2011) Rong Zhang et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

CYP3A4 Catalytic Activity Is Induced in Confluent Huh7 Hepatoma Cells

(2010) L. Sivertsson et al.   DRUG METABOLISM AND DISPOSITION

Novel immortalized human fetal liver cell line, cBAL111, has the potential to differentiate into functional hepatocytes

(2009) Tanja Deurholt et al.   BMC BIOTECHNOLOGY

Induction of UGT1A1 and CYP2B6 by an Antimitogenic Factor in HepG2 Cells Is Mediated through Suppression of Cyclin-Dependent Kinase 2 Activity: Cell Cycle-Dependent Expression

(2009) J. Sugatani et al.   DRUG METABOLISM AND DISPOSITION

Down-Regulation of Hepatic HNF4α Gene Expression during Hyperinsulinemia via SREBPs

(2009) Xuefen Xie et al.   MOLECULAR ENDOCRINOLOGY

Cell Lines: A Tool for In Vitro Drug Metabolism Studies

(2008) M. Gomez-Lechon et al.   CURRENT DRUG METABOLISM

Expression of the Hepatic Specific V1 Messenger Ribonucleic Acid of the Human Growth Hormone Receptor Gene Is Regulated by Hepatic Nuclear Factor (HNF)-4α2 and HNF-4α8

(2007) Cynthia Gates Goodyer et al.   MOLECULAR ENDOCRINOLOGY